Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases

As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets. Promising ne...

Full description

Saved in:
Bibliographic Details
Corporate Author SpringerLink (Online service)
Other Authors Mina-Osorio, Paola (Editor)
Format Electronic eBook
LanguageEnglish
Published Cham : Springer International Publishing : Imprint: Springer, 2017.
SeriesProgress in Inflammation Research
Subjects
Medicine.
Pharmacy.
Gene therapy.
Immunology.
Pharmaceutical technology.
elektronické knihy
electronic books
Online AccessFull text
ISBN9783319422527
DOI10.1007/978-3-319-42252-7
Physical DescriptionXI, 202 p. 8 illus., 6 illus. in color. online resource.

Cover

Table of Contents:
  • Preface
  • Targeted drug delivery
  • I. Bispecific antibodies
  • II. Targeting neovessels with NGR peptides
  • Genomic-based drugs
  • III. Micro-RNA/aptamers
  • Nanomedicine
  • IV. Exosomes
  • V. Microparticles
  • Cross-functional targets
  • VI. Metabolic targets in inflammation
  • VII. Targeting gut microbiome-immune system interactions
  • VIII. Targeting the nervous system as an add on therapy for autoinflammatory conditions
  • Biomarkers
  • IX. Biomarkers in drug discovery
  • Other therapies
  • X. Stem cell therapy in the treatment of rheumatic disease and application in the treatment of systemic lupus erythematosus.

Similar Items